Acute hepatic failure and hepatic encephalopathy after receiving a HRZE antitubercular regimen

Xiao-yuan ZHENG,En-juan ZHANG,Zhe ZHANG

DOI: https://doi.org/10.3760/cma.j.issn.1008-5734.2013.02.19

2013-01-01

Abstract:A 25-year-old female patient with pulmonary and intestinal tuberculosis received a HRZE antitubercular regimen comprising isoniazid (H) 0.3 g once daily,rifampicin (R) 0.45 g once daily,pyrazinamide (Z) 3 g once every three days,ethambutol (E) 0.75 g once daily.Three days later,she developed hepatic dysfunction.Six days later,she developed acute hepatic failure with hepatic encephalopathy.Laboratory tests showed the following values:alanine aminotransferase (ALT) 519 U/L,aspartate transaminase (AST) 1854 U/L,albumin 29.6 g/L,total bilirubin (TBil) 89.9 μmol/L,direct bilirubin (DBil) 59.2 μmol/L,prothrombin time 113 s,intemational normalized ratio 9.18,D-dimer 0.8 mg/L.All antitubercular agents were stopped,polyene phosphatidyl choline,reduced glutathione,ademetionine l,4-butanedisulfonate,alprostadil,Xiangdan injection（香丹注射液）were given.On day 9,she presented with coma,fructose sodium diphosphate and mannitol were added to her regimen.She received plasma exchange and transfusions of fresh frozen plasma and cryoprecipitate.On day 11,she revived and supportive therapy was continued.One month later,repeat testing showed the following results:ALT 25 U/L,AST 64 U/L,albumin 39.4 g/L,TBil 65.8 μmol/L,DBil 40.2 μmoL/L.